Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AMY2A | P04746 | 1/20 | 0.31 |
| ▸ | MGAM | O43451 | 2/20 | 0.31 |
| ▸ | SI | P14410 | 2/20 | 0.31 |
| ▸ | OGA | O60502 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15945033 | 0.81 | — | — | |
| SCHEMBL15945031 | 0.81 | — | — | |
| SCHEMBL22698185 | 0.75 | LMNA (0.36) | — | |
| SCHEMBL13227665 | 0.75 | LMNA (0.36) | — | |
| SCHEMBL9651142 | 0.75 | LMNA (0.36) | — | |
| SCHEMBL28361173 | 0.75 | LMNA (0.36) | — | |
| SCHEMBL14418383 | 0.70 | FGF1 (0.42) | AMY2A | |
| SCHEMBL28801107 | 0.68 | FUCA1 (0.39) | OGA | |
| SCHEMBL1979122 | 0.67 | LGALS8 (0.33) | AMY2AMGAMSIOGA | |
| SCHEMBL1870755 | 0.67 | LGALS8 (0.36) | OGA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140227793-A1 | COMPOSITIONS AND METHODS FOR GLYCAN SEQUENCING | NATIONAL SCIENCE FOUNDATION | 2014-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140227793-A1 | COMPOSITIONS AND METHODS FOR GLYCAN SEQUENCING | ST3GAL3, OSTC, MLX | AMY2A 322/4885MGAM 5/4885SI 85/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.